SF3B1 mutation is a prognostic factor in chronic lymphocytic leukemia: a meta-analysis

Recent studies suggest that SF3B1 might be related to poor prognosis in CLL, but the results remain controversial. This meta-analysis was performed to clarify the relationship between SF3B1 mutation and prognosis in patients with CLL. The relevant published reports were searched in PubMed, EMBASE, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhenghao, Chen, Shu, Chen, Shuang, Chen, Gang, Zhang, Rui, Li, Jinhua, Qu, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642526/
https://www.ncbi.nlm.nih.gov/pubmed/29050251
http://dx.doi.org/10.18632/oncotarget.19455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642526/
https://www.ncbi.nlm.nih.gov/pubmed/29050251
http://dx.doi.org/10.18632/oncotarget.19455

Ejemplares similares